FIGURE 3.

Evaluation of 6″-¹⁸F-fluoromaltotriose in inflammation. (A) Representative hematoxylin and eosin–stained sections of formalin-fixed lungs from control mice (left) and from mice with LPS-induced lung inflammation (right) showing thickening of bronchial walls (red arrow) due to accumulation of neutrophils and macrophages (stained blue). (B) Ex vivo biodistribution quantitation of lungs from immunocompetent control mice (n = 5) and mice after LPS-induced lung inflammation (n = 5), 24 h after administration of LPS intranasally and 1 h after intravenous administration of 6″-¹⁸F-fluoromaltotriose. Error bars represent SD of means.